Literature DB >> 7611508

Cardiovascular actions of adrenomedullin in conscious sheep.

D G Parkes1.   

Abstract

Adrenomedullin (Adm) is a 52-amino acid peptide that promotes a potent vasodilator action in rats and elevates adenosine 3',5'-cyclic monophosphate levels in isolated vascular tissue preparations. To date, the cardiovascular activity of Adm has been examined only in anesthetized animals, hence the present study examines in detail the hemodynamic actions of human Adm-(1-52) in conscious, chronically instrumented sheep. Five sheep were injected intravenously with 0.1, 1, 10, 50, or 100 micrograms Adm, and mean arterial pressure, heart rate (HR), cardiac output (CO), stroke volume (SV), total peripheral conductance (TPC), coronary blood flow (CF), coronary conductance (CC), peak aortic flow (Fmax), and left ventricular dF/dt were monitored by a computer-based data collection system. Adm produced dose-dependent changes in all parameters measured, with the threshold dose being 10 micrograms. Adm injected at 100 micrograms rapidly and significantly decreased blood pressure by 10 +/- 1 mmHg, accompanied by an increase in HR of 35 +/- 4 beats/min. CO increased by 1.6 +/- 0.3 l/min, whereas SV exhibited a small reduction of 11 +/- 4 ml/beat. TPC was markedly increased by 35 +/- 7 ml.min-1.mmHg-1. CF showed an increase of 27 +/- 4 ml/min, and CC increased in parallel by 0.45 +/- 0.06 ml.min-1. mmHg-1. Fmax and dF/dt showed small increases of 3.8 +/- 0.8 l/min and 104 +/- 12 l.min-1.s-1, respectively. All hemodynamic parameters had returned to control values by 40 min postinjection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611508     DOI: 10.1152/ajpheart.1995.268.6.H2574

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.

Authors:  P Hasbak; A Sams; S Schifter; J Longmore; L Edvinsson
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

Review 2.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

3.  Cirrhotic cardiomyopathy.

Authors:  Florence Wong
Journal:  Hepatol Int       Date:  2008-11-11       Impact factor: 6.047

4.  Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity.

Authors:  Y Miyao; T Nishikimi; Y Goto; S Miyazaki; S Daikoku; I Morii; T Matsumoto; S Takishita; A Miyata; H Matsuo; K Kangawa; H Nonogi
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

5.  Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide.

Authors:  R De Matteo; C N May
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

Review 6.  Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases.

Authors:  Toshihiro Kita; Kazuo Kitamura
Journal:  Hypertens Res       Date:  2022-01-06       Impact factor: 5.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.